Journals / Ege Tıp Dergisi / 2021 / Cilt: 60 - Sayı: 1

Relationship between magnesium / phosphate ratio and endothelial function in coronary artery disease: A prospective study

Koroner arter hastalığında magnezyum/fosfat oranı ile endotel fonksiyonları arasındaki ilişki: Bir prospektif çalışma

Pages
76–82
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In patients with coronary artery disease, magnesium / phosphate ratios can be used as a parameter reflecting endothelial function.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The pathogenesis of atherosclerotic changes and endothelial dysfunction is complex and multifactorial.
📊
Key Findings & Data:Results: Mean age of patients was 61.2 ± 10.1 years, and 72% of the patients were male and the mean body mass index was 27.8 ± 5.4 kg/m2.
💡
Conclusion & Impact:Conclusion: In patients with coronary artery disease, magnesium / phosphate ratios can be used as a parameter reflecting endothelial function.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: The pathogenesis of atherosclerotic changes and endothelial dysfunction is complex and multifactorial. Magnesium and phosphate minerals are important blood minerals in the pathophysiology of atherogenesis and endothelial dysfunction. Flow-mediated vasodilation test is known as one of the most valuable examination in evaluation of endothelial functions. Our study’s aim was to evaluate the relationship between magnesium / phosphate ratio and endothelial functions in patients with coronary artery disease. Materials and Methods: Sixty-one patients who had had coronary angiography and diagnosed with coronary artery disease were consecutively included. Endothelial functions were evaluated by flow-mediated vasodilation test on the radial artery during outpatient visit. Spearman correlation was used to evaluate the correlation between the Mg / P ratio and the FMD percentile change. Results: Mean age of patients was 61.2 ± 10.1 years, and 72% of the patients were male and the mean body mass index was 27.8 ± 5.4 kg/m2. In the flow-mediated vasodilation test, the mean radial artery basal diameter was 0.25 ± 0.03 cm, and the mean radial artery diameter after FMD was 0.28 ± 0.03 cm. A positive correlation was observed between magnesium / phosphate ratio and the percentage change in artery diameter implying endothelial functions (r = 0.268, p = 0.037). Conclusion: In patients with coronary artery disease, magnesium / phosphate ratios can be used as a parameter reflecting endothelial function.

Özet

Amaç: Aterosklerotik değişikliklerin ve endotel disfonksiyonunun patogenezi karmaşık ve çok faktörlüdür. Kandaki elektrolitlerden magnezyum ve fosfat mineralleri aterogenez ve endotel fonksiyon bozukluğunun patofizyolojisinde yer alan önemli minerallerdir. Endotel fonksiyonu değerlendirmede en çok kabul görmüş akım aracılı vazodilatasyon testidir. Çalışmamızda, koroner arter hastalığı olan hastalarda magnezyum/fosfat oranı ile endotel fonksiyonları arasındaki ilişkinin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Koroner anjiyografi ile belgelenmiş koroner arter hastalığı olan ardışık 61 hasta çalışmaya dahil edildi. Radial arterden akım aracılı vazodilatasyon testi ile endotel fonksiyonları poliklinik kontrolünde incelendi. Magnezyum/fosfat oranı ile akım aracılı vazodilatasyon yüzdelik değişimi arasındaki korelasyonu değerlendirmek için Spearman korelasyon analizi kullanıldı. Bulgular: Hastaların ortalama yaşı 61,2±10,1 yıl olup hastaların %72’si erkek ve ortalama vücut kitle indeksi 27,8±5,4 kg/m2’dir. AAD testinde ortalama radial arter bazal çapı 0,25±0,03 cm, test sonrası ortalama radial arter çapı 0,28±0,03 cm olarak saptandı. Magnezyum/fosfat oranları ile endotel fonksiyonlarını gösteren arter çapındaki yüzdelik değişim arasında pozitif yönde bir ilişki saptandı (r = 0,268, p = 0,037). Sonuç: Koroner arter hastalığı olan hastalarda, magnezyum/fosfat oranı endotel fonksiyonlarının bir göstergesi olarak kullanılabilir.

🔖

Cite This Article

SOYDAN, E., AKIN, M. (2022). Relationship between magnesium / phosphate ratio and endothelial function in coronary artery disease: A prospective study. Ege Tıp Dergisi, Cilt: 60 - Sayı: 1, 76–82. https://ajindex.com/articles/496042

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Widlansky ME, Gokce N, Keaney JF, et al. The clinical implications of endothelial dysfunction, J Am Coll Cardiol. 2003; 42 (7): 1149-60
  2. Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med. 1999; 340: 115–26
  3. Volpe SL. Magnesium, the metabolic syndrome, insulin resistance, and type 2 diabetes mellitus. Crit Rev Food Sci Nutr. 2008; 48: 293–300
  4. Kolte D, Vijayaraghavan K, Khera S, et al. Role of magnesium in cardiovascular diseases. Cardiol Rev. 2014; 22: 182–92
  5. Del Gobbo LC, Imamura F, Wu JH, et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. 2013; 98: 160–73
  6. Fang X, Liang C, Li M, et al. Dose-response relationship between dietary magnesium intake and cardiovascular mortality: a systematic review and dose-based meta-regression analysis of prospective studies. J Trace Elem Med Biol. 2016; 38: 64–73
  7. Maier JA, Malpuech-Brugère C, Zimowska W, et al. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta. 2004;1689(1):13-21
  8. Tonelli M, Sacks F, Pfeffer M, et al. Cholesterol And Recurrent Events Trial Investigators. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005; 112 (17): 2627-33
  9. Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007; 167: 879–85
  10. Ganesh SK, Stack AG, Levin NW, et al. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol. 2001; 12: 2131–8
  11. Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: a review. Clin Cardiol. 1997; 20: 426–32
  12. Anderson TJ, Meredith IT, Yeung AC, et al. The effects of cholesterol lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995; 332: 488–93
  13. Raitakari OT, Celermajer DS. Flow-mediated dilatation. Br J Clin Pharmacol. 2000; 50: 397-404
  14. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002; 105: 546-9
  15. McLenachan JM, Williams JK, Fish RD, et al. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation. 1991